Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 8,290.00
-10.00 (-0.12%)
At close: May 8, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 101.88 billion as of May 11, 2026. Its market cap has increased by 19.60% in one year.
Market Cap
101.88B
Enterprise Value
83.82B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8,290.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 101.88B, a decrease of -9.66%. That is a compound annual growth rate of -3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 101.88B | -16.19% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 134.94B |
| HYUNDAI BIOLAND | 134.25B |
| Organoidsciences | 130.13B |
| KOREA PHARMA | 120.85B |
| H.PIO | 114.13B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 112.61B |
| Polaris AI Pharma | 100.69B |
| Sam-A Pharm. | 98.75B |